AEON Biopharma(AEON)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

AEON AEON Biopharma

交易中 06-22 14:11:01 EDT

0.6756

+0.0093

+1.40%

最高0.6800	最低0.6700	成交量7,398
今开0.6800	昨收0.6663	日振幅1.50%
总市值1,777万	流通市值734.47万	总股本2,631万
成交额4,993	换手率0.07%	流通股本1,087万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"AEON","market":"US","secType":"STK","nameCN":"AEON Biopharma","latestPrice":0.6756,"timestamp":1782151332151,"preClose":0.6663,"halted":0,"volume":7398,"delay":0,"changeRate":0.01395767672219717,"floatShares":10871300,"shares":26307211,"eps":-4.16,"marketStatus":"交易中","change":0.0093,"latestTime":"06-22 14:11:01 EDT","open":0.68,"high":0.68,"low":0.67,"amount":4993.4036466,"amplitude":0.015008,"askPrice":0.6756,"askSize":6,"bidPrice":0.67,"bidSize":92,"shortable":0,"etf":0,"ttmEps":-4.16,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1782158400000},"marketStatusCode":2,"adr":0,"exchange":"AMEX","adjPreClose":0.6663,"preHourTrading":{"tag":"盘前","latestPrice":0.668,"preClose":0.6663,"latestTime":"07:00 EDT","volume":175,"amount":116.9,"timestamp":1782126009946,"change":0.0017,"changeRate":0.002551,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":0.668,"preClose":0.668,"latestTime":"18:55 EDT","volume":233,"amount":152.4007,"timestamp":1781823306647,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.247233},"requestUrl":"/m/hq/s/AEON","defaultTab":"news","newsList":[{"id":"2641198068","title":"AEON CREDIT遭FMR LLC减持139.8万股 每股作价约8.52港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2641198068","media":"新浪港股","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2641198068?lang=zh_cn&edition=full","pubTime":"2026-06-05 07:48","pubTimestamp":1780616880,"startTime":"0","endTime":"0","summary":"热点栏目\n\n自选股\n数据中心\n行情中心\n资金流向\n模拟交易\n\n客户端\n\n\n　　香港联交所最新数据显示，5月29日，FMR LLC减持AEON CREDIT（00900）139.8万股，每股作价8.5202港元，总金额约为1191.12万港元。减持后最新持股数目约为4187.11万股，最新持股比例为9.99%。\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：卢昱君","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2026-06-05/doc-iniaicva8714516.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4139","00900","BK1188","EWH","AEON"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640153718","title":"AEON CREDIT(00900)：公众持股量恢复至约为29.57%","url":"https://stock-news.laohu8.com/highlight/detail?id=2640153718","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640153718?lang=zh_cn&edition=full","pubTime":"2026-06-04 16:57","pubTimestamp":1780563467,"startTime":"0","endTime":"0","summary":"AEON CREDIT(00900)发布公告，公司已于2026年6月3日接获FMR \nLLC知会，彼等于2026年5月29日于场内合共出售139.8万股股份，占已发行股份总数约0.33%后，FMR \nLLC被视作持有的权益合计为4187.11万股，占于本公告日已发行股份总数约9.99%。","market":"us","thumbnail":"https://img.zhitongcaijing.com/gonggao/ztcj_announce_47.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/gonggao/ztcj_announce_47.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1450135.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK4139","BK1188","AEON","00900"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640917340","title":"AEON CREDIT(00900)：公众持股量约为19.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2640917340","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640917340?lang=zh_cn&edition=full","pubTime":"2026-06-02 19:07","pubTimestamp":1780398469,"startTime":"0","endTime":"0","summary":"智通财经APP讯，AEONCREDIT(00900)发布公告，于本公告日，本公司的公众持股量约为19.25%，已跌至低于香港联合交易所有限公司证券上市规则第13.32B(1)条所订明须由公众人士持有不少于本公司已发行股份总数的25%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1449205.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["AEON","BK4139","00900","BK1188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636734670","title":"AI 结算层 AEON 完成 800 万美元 Pre-Seed 轮融资，YZi Labs 领投","url":"https://stock-news.laohu8.com/highlight/detail?id=2636734670","media":"链捕手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636734670?lang=zh_cn&edition=full","pubTime":"2026-05-18 20:00","pubTimestamp":1779105628,"startTime":"0","endTime":"0","summary":" ChainCatcher 消息，据 The Block 报道，AI 结算层 AEON 完成 800 万美元 Pre-Seed 轮融资，YZi Labs 领投，IDG Capital、HashKey Capital、Stanford Blockchain Builders Fund 与 Oak Grove Ventures 等参投。此轮融资的结构和投后估值未披露。AEON 计划利用此轮资金开发旨在支持 AI 代理之间交互的结算层。\n\nAEON 于 5 月推出了首款 AI 支付产品，使 AI agent 能够连接全球超过 5000 万家实体商户。此外，AEON 还与 BNB Chain 合作推出了原生构建在 BNB Chain 基础设施上的产品 x402 Facilitator，为 BNB 生态系统内的服务提供商提供可验证交易、链上结算和不可篡改的收据。 ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.chaincatcher.com/article/2265528","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AIPO","BK4139","AEON","CHAT","ARTY","AGIX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632931356","title":"AEON CREDIT(00900)：李澄明退任独立非执行董事","url":"https://stock-news.laohu8.com/highlight/detail?id=2632931356","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2632931356?lang=zh_cn&edition=full","pubTime":"2026-05-04 17:05","pubTimestamp":1777885542,"startTime":"0","endTime":"0","summary":"智通财经APP讯，AEON CREDIT(00900)发布公告，本公司独立非执行董事李澄明先生(李先生)，将不会于2026年6月25日本公司举行的股东周年大会上膺选连任，并将于2026年度股东周年大会结束时退任，以便投放更多时间处理其其他个人事务。当李先生退任后，李先生将不再为本公司薪酬委员会主席，以及策略委员会成员。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1437849.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4139","BK1188","00900","AEON"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627745193","title":"永旺(00984)拟斥资不超过约1.7亿元收购AEON GD合共35%股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2627745193","media":"智通财经","labels":["shareholding","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627745193?lang=zh_cn&edition=full","pubTime":"2026-04-13 22:53","pubTimestamp":1776092004,"startTime":"0","endTime":"0","summary":"智通财经APP讯，永旺(00984)公布，于2026年4月13日(交易时段后)，董事会议决透过公开招标方式投标，以收购天河城百货所持AEON GD合共35%股权，总代价不超过约人民币1.7亿元。于建议收购完成后，公司将持有AEON GD全部股权。AEON GD主要于中国从事零售店铺经营。公司认为，此为集团进一步增持AEON GD股权的好机会。公司相信，透过增加于AEON GD的股权将使公司持有AEON GD100% 股权，将可更有效地整合及精简AEON GD所控制的店铺连同于中国的其他店铺的营运，从而达致更佳规模经济效益。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1427998.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,merge","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1122","BK1249","BK4139","GD","BK4187","00984","BK4585","BK4588","AEON","LU0170899867.USD","BK4550","BK4516","BK4566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623372526","title":"AEON CREDIT(00900)公布年度业绩 净利约4.68亿港元 同比增长16.91% 末期息每股33港仙","url":"https://stock-news.laohu8.com/highlight/detail?id=2623372526","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2623372526?lang=zh_cn&edition=full","pubTime":"2026-03-31 12:10","pubTimestamp":1774930223,"startTime":"0","endTime":"0","summary":"智通财经APP讯，AEON CREDIT(00900)公布截至2026年2月28日止年度业绩，收入约18.25亿港元，同比增长3.75%;净利约4.68亿港元，同比增长16.91%;基本每股盈利111.80港仙， 拟派发末期股息每股33.0港仙。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1422788.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4139","BK1188","AEON","00900"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1148829509","title":"AEON Biopharma公布2025财年全年业绩，并强调ABP-450生物类似药项目获得积极对比分析结果及FDA反馈","url":"https://stock-news.laohu8.com/highlight/detail?id=1148829509","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1148829509?lang=zh_cn&edition=full","pubTime":"2026-03-31 04:06","pubTimestamp":1774901175,"startTime":"0","endTime":"0","summary":"AEON Biopharma已发布其2025财年全年财务业绩报告。同时，公司重点通报了其ABP-450生物类似药项目的积极进展，包括正向的对比分析研究结果以及美国食品药品监督管理局（FDA）提供的反馈意见。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","AEON"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1197916426","title":"AEON Biopharma Inc：FDA支持AEON在351(K)生物类似药路径下的分析相似性策略","url":"https://stock-news.laohu8.com/highlight/detail?id=1197916426","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1197916426?lang=zh_cn&edition=full","pubTime":"2026-03-25 20:04","pubTimestamp":1774440262,"startTime":"0","endTime":"0","summary":"美国食品药品监督管理局（FDA）已表态支持AEON Biopharma公司依照351(K)生物类似药审批路径所提出的分析相似性研究策略。这一积极信号意味着，AEON在推进其生物类似药研发过程中，所采用的关键技术路线获得了监管机构的认可。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","AEON"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620237839","title":"$SUN 集成 AEON Pay  全球超 5000 万商户支持加密支付","url":"https://stock-news.laohu8.com/highlight/detail?id=2620237839","media":"链捕手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620237839?lang=zh_cn&edition=full","pubTime":"2026-03-18 18:54","pubTimestamp":1773831299,"startTime":"0","endTime":"0","summary":" ChainCatcher 消息，据官方消息，$SUN 正式集成 AEON Pay，开启加密支付新纪元，现 $SUN 已全面接入 AEON Pay 支付系统，覆盖全球超 5000 万线上线下商户，用户可在购物、餐饮、娱乐等多元场景中轻松使用 $SUN 进行支付。\n\n此次 $SUN 与 AEON Pay 的战略合作，不仅是波场生态流动性向日常消费场景的大规模延伸，更是 $SUN 布局 AI 驱动型数字经济的重要里程碑，$SUN 正在从单纯的加密资产向数字经济时代的核心支付工具加速进化。\n ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.chaincatcher.com/article/2252738","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4590","SUN","BK4138","BK4139","AEON"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614624048","title":"AEON CREDIT(00900.HK)续订屯门店铺特许权协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2614624048","media":"中金财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614624048?lang=zh_cn&edition=full","pubTime":"2026-02-26 19:17","pubTimestamp":1772104623,"startTime":"0","endTime":"0","summary":"格隆汇2月26日丨AEON CREDIT(00900.HK)公告，于2026年2月26日，公司(作为特许权使用者)与永旺百货(作为特许权许可者)就店铺租赁之租赁期订立2026年屯门特许权协议以续订现有屯门特许权协议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260226/32029995.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["00900","BK1188","AEON","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614304862","title":"AEON CREDIT(00900.HK)续签AEON商标品牌使用权协议 年期一年","url":"https://stock-news.laohu8.com/highlight/detail?id=2614304862","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614304862?lang=zh_cn&edition=full","pubTime":"2026-02-26 19:17","pubTimestamp":1772104623,"startTime":"0","endTime":"0","summary":"格隆汇2月26日丨AEON CREDIT(00900.HK)公告，于2026年2月26日，公司与AFS日本订立2026年品牌使用权续约协议，据此，公司应就有关集团于地区内之业务而使用AEON商标向AFS日本支付使用权费，该协议年期由2026年3月1日起至2027年2月28日，为期一年。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260226/32029994.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["00900","BK1188","AEON","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614612390","title":"AEON 累计交易额突破 2.63 亿美元，AI 原生支付规模呈增长趋势","url":"https://stock-news.laohu8.com/highlight/detail?id=2614612390","media":"链捕手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614612390?lang=zh_cn&edition=full","pubTime":"2026-02-26 09:58","pubTimestamp":1772071099,"startTime":"0","endTime":"0","summary":" ChainCatcher 消息，AI 经济支付与结算层 AEON 披露其 2025 年运营数据，旗下产品 AI Payment 及 Web3 移动支付产品 AEON Pay 全年累计处理交易 570万笔，交易总额超过 2.63 亿美元，全球服务用户达 181 万，AI 原生支付规模呈增长趋势。目前，AEON 的支付网络已覆盖东南亚、拉美及非洲等地区超过 5000 万商户，支持 x402、ERC-8004 等 AI 支付标准，推动 AI 原生支付在真实商业场景中的落地应用。 ","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.chaincatcher.com/article/2247974","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AEON","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2613022713","title":"年度上限1440万港元 AEON CREDIT续签控股股东金融顾问服务协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2613022713","media":"财中社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613022713?lang=zh_cn&edition=full","pubTime":"2026-02-24 19:46","pubTimestamp":1771933618,"startTime":"0","endTime":"0","summary":"AEONCREDIT（00900）发布公告，2026年2月24日，公司与AFS日本签署了2026年续约协议。根据该协议，AFS日本将为公司提供与金融行业相关的咨询及顾问服务，服务期限自2026年3月1日起至2027年2月28日，为期一年。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202602243652924818.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4139","BK1188","AEON","00900","159940"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1107170090","title":"AEON Biopharma公布与FDA举行B型2a期会议及股东批准11月交易事项","url":"https://stock-news.laohu8.com/highlight/detail?id=1107170090","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1107170090?lang=zh_cn&edition=full","pubTime":"2026-01-22 05:06","pubTimestamp":1769029572,"startTime":"0","endTime":"0","summary":"AEON Biopharma宣布，公司已顺利完成与美国食品药品监督管理局（FDA）就B型2a期临床试验举行的专题会议，并就11月达成的相关交易事项获得股东正式批准。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","AEON"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2595479315","title":"AEON 宣布集成 OKX 推出的 X Layer，扫码支付能力已嵌入 OKX Pay 扩展至多地线下场景","url":"https://stock-news.laohu8.com/highlight/detail?id=2595479315","media":"链捕手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595479315?lang=zh_cn&edition=full","pubTime":"2025-12-30 17:20","pubTimestamp":1767086421,"startTime":"0","endTime":"0","summary":" ChainCatcher 消息，AI 经济支付与结算层 AEON 宣布集成 OKX 推出的 Layer2 X Layer，其扫码支付功能已接入 X Layer，使 X Layer 上的相关资产可在东南亚、非洲及拉美地区的 5000 万线上与线下商户中使用。此次合作也将此 AEON 线下移动支付能力嵌入 OKX Pay，用户可直接在 OKX Pay 内使用 X Layer 资产完成日常消费。\n\nAEON 已与多个主流钱包和交易所达成合作，赋能数千万用户使用加密资产在现实世界完成消费，包括 Binance Wallet, Bitget Wallet, KuCoin, Bybit, TokenPocket, Solana Pay, OKX Wallet 等。 ","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.chaincatcher.com/article/2233645","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AEON","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2595446785","title":"AEON 与 United Stables 达成合作，$U 同时接入线下扫码支付与 BNB Chain x402 原生 AI 结算场景","url":"https://stock-news.laohu8.com/highlight/detail?id=2595446785","media":"链捕手","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595446785?lang=zh_cn&edition=full","pubTime":"2025-12-29 17:06","pubTimestamp":1766999183,"startTime":"0","endTime":"0","summary":" ChainCatcher 消息，AI 经济支付与结算层 AEON 宣布与稳定币发行商 United Stables 展开合作，AEON Pay 扫码支付现已支持使用 $U 进行线下消费，用户可通过 Binance Wallet AEON Pay dApp 完成支付，覆盖全球 5000 万商户日常购物、餐饮等真实场景。此外，AEON 的 x402 facilitator 也已支持 $U，并将其在 BNB Chain 上作为结算资产使用，服务 x402 AI 原生支付与自动化交易场景。\n ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.chaincatcher.com/article/2233343","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AEON","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518927276","title":"Aeon Biopharma, Inc.盘中异动 股价大涨12.56%报0.743美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518927276","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518927276?lang=zh_cn&edition=full","pubTime":"2025-03-10 21:31","pubTimestamp":1741613515,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日21时31分，Aeon Biopharma, Inc.股票出现波动，股价快速上涨12.56%。截至发稿，该股报0.743美元/股，成交量22.6647万股，换手率20.41%，振幅1.06%。Aeon Biopharma, Inc.股票所在的生物技术行业中，整体跌幅为0.59%。Aeon Biopharma, Inc.公司简介：AEON Biopharma Inc 是一家临床阶段的生物制药公司，专注于开发其专有的肉毒杆菌毒素复合物 ABP-450注射剂，用于衰弱的医疗状况，最初的重点是神经科学市场。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310213155abf2fc23&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310213155abf2fc23&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AEON"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517165531","title":"Aeon Biopharma, Inc.盘中异动 早盘股价大涨11.60%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517165531","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517165531?lang=zh_cn&edition=full","pubTime":"2025-03-06 22:32","pubTimestamp":1741271566,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日22时32分，Aeon Biopharma, Inc.股票出现波动，股价快速拉升11.60%。Aeon Biopharma, Inc.股票所在的生物技术行业中，整体跌幅为0.66%。Aeon Biopharma, Inc.公司简介：AEON Biopharma Inc 是一家临床阶段的生物制药公司，专注于开发其专有的肉毒杆菌毒素复合物 ABP-450注射剂，用于衰弱的医疗状况，最初的重点是神经科学市场。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306223246a2629031&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306223246a2629031&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AEON"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517591021","title":"Aeon Biopharma, Inc.盘中异动 股价大跌5.42%报0.454美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517591021","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517591021?lang=zh_cn&edition=full","pubTime":"2025-03-05 22:31","pubTimestamp":1741185085,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日22时31分，Aeon Biopharma, Inc.股票出现波动，股价急速下挫5.42%。截至发稿，该股报0.454美元/股，成交量35.5144万股，换手率31.97%，振幅0.00%。Aeon Biopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.08%。Aeon Biopharma, Inc.公司简介：AEON Biopharma Inc 是一家临床阶段的生物制药公司，专注于开发其专有的肉毒杆菌毒素复合物 ABP-450注射剂，用于衰弱的医疗状况，最初的重点是神经科学市场。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305223126abe9b089&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305223126abe9b089&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AEON"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.aeonbiopharma.com","stockEarnings":[{"period":"1week","weight":-0.0388},{"period":"1month","weight":-0.2188},{"period":"3month","weight":-0.3757},{"period":"6month","weight":-0.3815},{"period":"1year","weight":-0.1325},{"period":"ytd","weight":-0.3927}],"compareEarnings":[{"period":"1week","weight":0.0122},{"period":"1month","weight":0.0177},{"period":"3month","weight":0.1514},{"period":"6month","weight":0.0972},{"period":"1year","weight":0.2499},{"period":"ytd","weight":0.0951}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"AEON Biopharma, Inc.于2012年2月在特拉华州注册成立。该公司是一家临床阶段的生物制药公司，专注于开发专有肉毒毒素复合物ABP-450，用于使人衰弱的医疗状况，最初的重点是神经科学市场。该公司已完成ABP-450治疗颈肌张力障碍的2期研究，并正在进行ABP-450治疗慢性和发作性偏头痛的2期研究。第二阶段研究的发作性偏头痛队列的顶线数据于2023年10月报告，慢性偏头痛队列仍在进行中。ABP-450是目前Evolus以jeuveau的名称批准并上市的用于美容适应症的同种肉毒素复合物。ABP-450由Daewoong在FDA、加拿大卫生部和EMA批准的设施中按照cGMP生产。公司拥有ABP-450治疗适应症在美国、加拿大、欧盟、英国和某些国际地区的独家开发和分销权。公司打造了一支经验丰富的管理团队，在生物制药和肉毒毒素开发和商业化方面具有具体经验。","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":-0.140763},{"month":2,"riseRate":0.4,"avgChangeRate":-0.059786},{"month":3,"riseRate":0.4,"avgChangeRate":-0.072399},{"month":4,"riseRate":0.4,"avgChangeRate":-0.194565},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.073317},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.075508},{"month":7,"riseRate":0.8,"avgChangeRate":0.144696},{"month":8,"riseRate":0.2,"avgChangeRate":-0.166841},{"month":9,"riseRate":0.8,"avgChangeRate":0.082705},{"month":10,"riseRate":0.6,"avgChangeRate":-0.023886},{"month":11,"riseRate":0.4,"avgChangeRate":-0.065876},{"month":12,"riseRate":0.6,"avgChangeRate":0.111556}],"exchange":"AMEX","name":"AEON Biopharma","nameEN":"AEON Biopharma"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"AEON Biopharma(AEON)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供AEON Biopharma(AEON)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"AEON Biopharma,AEON,AEON Biopharma股票,AEON Biopharma股票老虎,AEON Biopharma股票老虎国际,AEON Biopharma行情,AEON Biopharma股票行情,AEON Biopharma股价,AEON Biopharma股市,AEON Biopharma股票价格,AEON Biopharma股票交易,AEON Biopharma股票购买,AEON Biopharma股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"AEON Biopharma(AEON)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供AEON Biopharma(AEON)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}